Key result
Loss of CSN6 or human desmosomal mutations that destabilize junctional CSN6 accelerated desmosomal proteome degradation and were sufficient to trigger arrhythmogenic right ventricular dysplasia/cardiomyopathy in mice.
Why the study?
No information existed on whether resident proteins regulate desmosomal proteome homeostasis, despite desmosomal destabilization and breakdown being a hallmark of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Identification of the CSN6 complex as a critical regulator of desmosomal protein homeostasis provides novel mechanistic insights into the pathogenesis of ARVD/C.
Dysregulated protein degradative pathways are increasingly recognized as mediators of human disease. This mechanism may have particular relevance to desmosomal proteins that play critical structural roles in both tissue architecture and cell-cell communication, as destabilization/breakdown of the desmosomal proteome is a hallmark of genetic-based desmosomal-targeted diseases, such as the cardiac disease arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). However, no information exists on whether there are resident proteins that regulate desmosomal proteome homeostasis. Here, we uncovered a cardiac constitutive photomorphogenesis 9 (COP9) desmosomal resident protein complex, composed of subunit 6 of the COP9 signalosome (CSN6), that enzymatically restricted neddylation and targeted desmosomal proteome degradation. CSN6 binding, localization, levels, and function were affected in hearts of classic mouse and human models of ARVD/C affected by desmosomal loss and mutations, respectively. Loss of desmosomal proteome degradation control due to junctional reduction/loss of CSN6 and human desmosomal mutations destabilizing junctional CSN6 were also sufficient to trigger ARVD/C in mice. We identified a desmosomal resident regulatory complex that restricted desmosomal proteome degradation and disease.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2021) studied Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). CSN6 deficiency and desmosomal mutations vs. Wild-type/control was evaluated on Desmosomal proteome degradation and ARVD/C phenotype. Loss of CSN6 or human desmosomal mutations that destabilize junctional CSN6 accelerated desmosomal proteome degradation and were sufficient to trigger arrhythmogenic right ventricular dysplasia/cardiomyopathy in mice.
Synapse has enriched 10 related papers. Consider them for comparative context: